1
Bailey Richard B, Madden Kevin T, Trueheart Joshua: Production of sterols in oleaginous yeast and fungi. Microbia Precision Engineering, Bailey Richard B, Madden Kevin T, Trueheart Joshua, LUITJENS Cameron M PhD, October 30, 2008: WO/2008/130372 (43 worldwide citation)

The present invention provides methods for production of one or more sterol compounds. Further provided are methods and systems for producing engineered oleaginous yeast or fungi that are capable of production of one or more sterol compounds, and compositions which utilize the produced sterol compou ...


2

3

4
Richard Bailey, Kevin T Madden, Joshua Trueheart: Production of carotenoids in oleaginous yeast and fungi. Microbia, Choate Hall & Stewart, Brenda Herschbach Jarrell, December 14, 2010: US07851199 (25 worldwide citation)

The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.


5
Mark G Currie, Shalina Mahajan Miklos, Thea Norman, G Todd Milne: Methods and compositions for the treatment of gastrointestinal disorders. Microbia, Fish & Richardson P C, December 4, 2007: US07304036 (22 worldwide citation)

The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflamm ...


6
MADDEN KEVIN T: Production of 1,4 butanediol in a microorganism. Microbia, Meiklejohn Anita L, July 29, 2010: WO/2010/085731 (21 worldwide citation)

A biological method for the conversion of L-glutamate to 1,4-butanediol that involves a decarboxylation step and avoids production of 4-hydroxybutyrate as an intermediate is described. The method includes: (a) conversion of L-glutamate to L-glutamate 5- phosphate; (b) conversion of L-glutamate 5 -ph ...


7
Zimmer Daniel P, Currie Mark G, Fretzen Angelika: Methods and compositions for the treatment of heart failure and other disorders. Microbia, Zimmer Daniel P, Currie Mark G, Milne G Todd, Fretzen Angelika, MEIKLEJOHN Anita L, September 4, 2008: WO/2008/106429 (21 worldwide citation)

Peptides that act as GC-C receptor agonists and contain at least one D-cys and are useful for the treatment of diuresis and heart disease as well as other disorders are described.


8
Martinez Eduardo, Talley John J, Zimmer Daniel P: 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia. Microbia, Martinez Eduardo, Talley John J, Zimmer Daniel P, TIMMER Edward, November 16, 2006: WO/2006/122186 (19 worldwide citation)

The invention relates to a chemical genus of 1,4-diphenyl-3-hydroxyalkyl-2-azetidinones useful for the treatment of hypercholesterolemia and related disorders, having general formula (I).


9
Mark G Currie, Shalina Mahajan Miklos, Angelika Fretzen, Li Jing Sun, Thea Norman, G Todd Milne: Methods and compositions for the treatment of gastrointestinal disorders. Microbia, Fish & Richardson P C, May 13, 2008: US07371727 (18 worldwide citation)

The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn's disease, ulce ...


10


Click the thumbnails below to visualize the patent trend.